What is the recommended sepsis bundle to initiate within the first hour for an adult patient with suspected sepsis or septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sepsis Bundle: Hour-1 Bundle Components

For adult patients with suspected sepsis or septic shock, initiate the following five critical interventions within the first hour of recognition: measure lactate, obtain blood cultures before antibiotics, administer broad-spectrum IV antibiotics, give 30 mL/kg crystalloid bolus for hypotension or lactate ≥4 mmol/L, and start vasopressors if hypotension persists despite fluid resuscitation. 1

The Five Hour-1 Bundle Elements

1. Measure Lactate Level

  • Obtain lactate immediately upon sepsis recognition and remeasure within 2-4 hours if initially elevated (≥2 mmol/L) 1
  • Target lactate normalization (<2 mmol/L) as a marker of adequate tissue perfusion 2, 1
  • Each 20-minute delay in obtaining lactate increases mortality risk 3

2. Obtain Blood Cultures Before Antibiotics

  • Draw at least two sets of blood cultures (aerobic and anaerobic bottles) before starting antibiotics 2, 1
  • Obtain one set percutaneously and one through any vascular access device present >48 hours 1
  • Never delay antibiotics beyond 45 minutes waiting for cultures 1, 4
  • Each 50-minute delay in obtaining blood cultures increases mortality 3

3. Administer Broad-Spectrum IV Antibiotics Within 1 Hour

  • Give IV broad-spectrum antibiotics within 60 minutes of sepsis recognition—this is the single most time-critical intervention 1
  • Each hour of antibiotic delay decreases survival by approximately 7.6% 1
  • Delays beyond 125 minutes significantly increase mortality risk 3
  • Empiric therapy must cover all likely pathogens (bacterial, fungal when appropriate) with adequate tissue penetration to the presumed infection source 1
  • If IV access is unavailable, use intraosseous or intramuscular administration rather than delaying therapy 1

Recommended empiric regimens:

  • Extended-spectrum β-lactam: piperacillin-tazobactam, cefepime, or carbapenem 1
  • Add aminoglycoside or fluoroquinolone for neutropenic patients, suspected multidrug-resistant organisms, or septic shock with respiratory failure 1

4. Rapid Fluid Resuscitation

  • Administer 30 mL/kg IV crystalloid bolus within the first 3 hours for hypotension or lactate ≥4 mmol/L 2, 1
  • Infuse rapidly over 5-10 minutes, titrating to clinical response 1
  • Use either balanced crystalloids or normal saline as initial fluid of choice 1
  • Delays beyond 100 minutes in completing fluid bolus increase mortality 3
  • Reassess hemodynamic status frequently after initial bolus: evaluate capillary refill, skin temperature, mental status, and urine output (target >0.5 mL/kg/hour) 2, 1

5. Initiate Vasopressors for Persistent Hypotension

  • Start vasopressors if hypotension persists despite adequate fluid resuscitation 1
  • Target mean arterial pressure (MAP) ≥65 mmHg 2, 1
  • Norepinephrine is the first-line vasopressor agent 1
  • Do not delay vasopressor initiation while obtaining additional vascular access 1

Critical Timing Evidence

The evidence strongly supports rapid bundle completion:

  • Completing all bundle components within 3 hours is associated with significantly lower 28-day mortality (17.5% vs. 31.4%) and improved 90-day survival 5
  • More rapid completion of the 3-hour bundle is associated with lower risk-adjusted in-hospital mortality (odds ratio 1.04 per hour delay) 6
  • However, completion within 1 hour versus 1-3 hours shows no significant mortality advantage (21.5% vs. 15.9%, p=0.4), suggesting the 1-3 hour window is acceptable 5

Ongoing Management and De-escalation

Daily Antimicrobial Reassessment

  • Reassess antibiotic therapy daily once culture and susceptibility results are available 1, 4
  • Narrow to the most appropriate single agent as soon as susceptibility profiles are known 1
  • Discontinue combination therapy within 3-5 days if clinical improvement occurs 1
  • Use procalcitonin levels to support discontinuing empiric antibiotics in patients with no subsequent evidence of infection 1

Source Control

  • Identify and control the infection source within 12 hours when feasible—do not delay surgical intervention or drainage procedures 1
  • Use the least physiologically invasive effective intervention (percutaneous drainage rather than open surgery when possible) 1

Common Pitfalls to Avoid

  • Do not wait for diagnostic certainty before initiating the bundle—sepsis is a medical emergency requiring immediate treatment 2, 1
  • Do not delay antibiotics to obtain "perfect" cultures—sterilization of cultures occurs within minutes to hours after the first antibiotic dose 2
  • Avoid inadequate initial fluid resuscitation, but monitor for fluid overload—use frequent reassessment rather than fixed volume targets beyond the initial 30 mL/kg 1
  • Do not use hydroxyethyl starches—they are contraindicated in sepsis 1
  • Failure to initiate appropriate empiric therapy increases mortality up to fivefold 4

Hemodynamic Targets During Resuscitation

Target the following endpoints 2:

  • Capillary refill time <2 seconds
  • Normal blood pressure for age (MAP >65 mmHg in adults)
  • Warm extremities
  • Urine output >0.5 mL/kg/hour
  • Normal mental status
  • Lactate <2 mmol/L

References

Guideline

Sepsis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Septic Abortion Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.